LASMIDITAN SUCCINATE | N211280 | ELI LILLY AND CO
| Case | Court | Filed | Status | Judge |
|---|---|---|---|---|
ELI LILLY & COMPANY et al v. QILU PHARMACEUTICAL CO., LTD. et al 1 patentANDA 219350lasmiditan | D.N.J. | 2026-03-19 | Terminated 2026-04-02 | — |
ELI LILLY & COMPANY et al v. QILU PHARMACEUTICAL CO., LTD. et al 1 patentANDA 219350lasmiditan | D.N.J. | 2025-06-30 | Terminated 2025-07-08 | — |
Eli Lilly & Company et al v. Humanwell Pharmaceutical US, Inc. et al 1 patentANDA 219669lasmiditan | MOED | 2025-03-21 | Terminated 2025-07-07 | — |
ELI LILLY & COMPANY et al v. HUMANWELL PHARMACEUTICAL US, INC. et al 1 patentANDA 219669lasmiditan | D.N.J. | 2025-03-21 | Terminated 2025-10-08 | — |
Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).